The featured leaders list highlights influential voices across biotechnology, pharmaceutical innovation, translational science, clinical development, regulation, manufacturing readiness, investment, and commercial strategy. Participation remains invitation-only — you cannot register directly unless your proposal or eligibility is accepted through the review workflow.
Only confirmed participants receive the registration pathway.
participation@executivecongresses.com
Curated leader sessions and roundtables are built for decisions, partnerships, licensing, and commercial outcomes.
A selection of recognised leaders relevant to EICBPI themes. Academicians are welcome — but still through the same invitation-only process (apply or submit a proposal first).
University of York, United Kingdom
Executive perspectives on biotechnology translation, therapeutic development, and research-to-application pathways.
University of Birmingham, United Kingdom
Strategic insight into genetic resources, resilience science, and biotechnology applications for future health and food systems.
National University of Ireland, Ireland
Research leadership across molecular inflammation, therapeutic targets, and translational pharmaceutical innovation.
Technical University of Munich, Germany
Perspectives on cellular systems, disease modelling, and biotechnology routes from laboratory research to applied innovation.
Brunel University London, United Kingdom
Insight into neurogenetic research, molecular disease pathways, and emerging therapeutic opportunities.
University of Luxembourg
Executive-level discussion on cytokine signalling, translational immunology, and precision therapeutic development.
Saarland University, Germany
Strategic perspectives on epigenomics, systems-level biology, and advanced biotechnology applications.
Biotechnology Research Institute, CAAS, China
Leadership insight into agricultural biotechnology, applied bioinnovation, and scalable research impact.
The Ohio State University, USA
Focused perspectives on biotechnology process strategy, collaborative innovation, and industry-ready development pathways.
Vilnius University, Lithuania
Insight into molecular biotechnology tools, epigenetic mechanisms, and platform technologies for research and therapeutics.
Environmental Biotechnology, Germany
Strategic discussion on environmental biotechnology, bioresource recovery, and sustainable biotechnology systems.
University of Ghent, Belgium
Perspectives on genomics, pharmaceutical biotechnology, and applied molecular innovation in regulated environments.
